• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用能达到生理水平剪切应力的灌注回路在体外研究溶栓剂的特性。

Properties of thrombolytic agents in vitro using a perfusion circuit attaining shear stress at physiological levels.

作者信息

Nishino N, Scully M F, Rampling M W, Kakkar V V

机构信息

Thrombosis Research Institute, Chelsea, London.

出版信息

Thromb Haemost. 1990 Dec 28;64(4):550-5.

PMID:2128138
Abstract

A perfusion circuit was designed to investigate in vitro some of the factors which may influence the success of thrombolytic treatment in vivo. The rate of lysis of clotted plasma and different types of artificial thrombi (fibrin thrombi or whole blood thrombi) was measured in citrated plasma or whole blood under static conditions or under shear stress equivalent to the arterial or venous circulation. With both streptokinase (SK) and tissue-type plasminogen activator (t-PA) the rate of lysis of fibrin thrombi and whole blood thrombi was reduced significantly, when compared to the conventional plasma gel clot model (25-fold and 8-fold, respectively). This occurred particularly with SK which showed a reduction (4-fold) in potency relative to t-PA under these conditions. Lysis of thrombi by both activators was observed to be faster in plasma than whole blood, and also faster with whole blood thrombi than fibrin thrombi. High shear stress, generally, caused a reduction in the rate of lysis of fibrin thrombi and an increase in the rate of lysis of whole blood thrombi compared to lysis rates under static conditions. Under all conditions of flow the lysis rate observed at 50 units t-PA per ml was much faster than that at 500 units per ml unlike the conventional plasma gel clot model.

摘要

设计了一种灌注回路,用于在体外研究一些可能影响体内溶栓治疗成功的因素。在枸橼酸盐血浆或全血中,于静态条件下或在相当于动脉或静脉循环的剪切应力下,测量凝固血浆和不同类型人工血栓(纤维蛋白血栓或全血血栓)的溶解速率。与传统的血浆凝胶凝块模型相比,使用链激酶(SK)和组织型纤溶酶原激活剂(t-PA)时,纤维蛋白血栓和全血血栓的溶解速率均显著降低(分别降低25倍和8倍)。在这些条件下,SK相对于t-PA的效力降低(4倍),这种情况尤其明显。观察到两种激活剂对血栓的溶解在血浆中比在全血中更快,并且对全血血栓的溶解比对纤维蛋白血栓更快。一般来说,与静态条件下的溶解速率相比,高剪切应力导致纤维蛋白血栓的溶解速率降低,全血血栓的溶解速率增加。在所有流动条件下,每毫升50单位t-PA时观察到的溶解速率比每毫升500单位时快得多,这与传统的血浆凝胶凝块模型不同。

相似文献

1
Properties of thrombolytic agents in vitro using a perfusion circuit attaining shear stress at physiological levels.使用能达到生理水平剪切应力的灌注回路在体外研究溶栓剂的特性。
Thromb Haemost. 1990 Dec 28;64(4):550-5.
2
Influence of intrinsic and extrinsic plasminogen upon the lysis of thrombi in vitro.内源性和外源性纤溶酶原对体外血栓溶解的影响。
Thromb Haemost. 1991 Dec 2;66(6):672-7.
3
Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.含重组组织型纤溶酶原激活剂(rt-PA)的血浆轴向湍流在体外可促进非闭塞性全血凝块的溶栓作用。
Thromb Haemost. 2004 Mar;91(3):487-96. doi: 10.1160/TH03-07-0447.
4
An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.组织型纤溶酶原激活剂溶解壁内纤维蛋白凝块的实验与理论研究
Biotechnol Bioeng. 2002 Feb 15;77(4):405-19.
5
Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.回缩对使用纤维蛋白特异性和非纤维蛋白特异性纤溶酶原激活剂溶解人血凝块的影响。
Thromb Haemost. 1989 Dec 29;62(4):1083-7.
6
Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.纤溶酶原激活剂的纤维蛋白特异性影响纤维蛋白溶解效率及对超声的反应性:九种纤溶酶原激活剂的体外比较
Thromb Haemost. 1999 Apr;81(4):605-12.
7
The effect of flow on lysis of plasma clots in a plasma environment.血流对血浆环境中血浆凝块溶解的影响。
Thromb Haemost. 2000 Mar;83(3):469-74.
8
Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.在犬动静脉联合血栓形成模型中组织型纤溶酶原激活剂与纤溶酶原激活剂抑制剂-1抗性糖基化变体的溶栓特性比较
Thromb Haemost. 1994 Jul;72(1):98-104.
9
The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility.人血栓中纤溶酶原、组织型纤溶酶原激活剂和1型纤溶酶原激活剂抑制剂的含量及其与体外溶解能力的关系。
Thromb Haemost. 1992 Jan 23;67(1):101-5.
10
Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.赖氨酸纤溶酶原对单链或双链尿激酶型纤溶酶原激活剂或组织型纤溶酶原激活剂所致血凝块溶解的增强作用。
Thromb Haemost. 1989 Jun 30;61(3):502-6.